Editor's Pick

Covid-19 vaccine: Why is Malaysia opting for mRNA?

The COVID-19 vaccine developed in Malaysia in collaboration with the Institute of Medical Research (IMR) and Universiti Putra Malaysia (UPM) will undergo pre-clinical trials involving animals starting next month and is expected to be completed by 2024.

MOH plans to open two more PKRCs in Klang Valley

Deputy Health Minister Datuk Dr Noor Azmi Ghazali said the proposed Covid-19 Low-Risk Quarantine and Treatment Centres will be located at Universiti Teknologi MARA (UiTM) Dengkil in Selangor and Grand Season Hotel in Kuala Lumpur, which ceased operations last year.

'Worrying' data shows about 33% of B40 group detected with non-communicable disease via PeKA B40 health screening — MoH

Health Minister Datuk Seri Dr Adham Baba: This number involves the B40 Group who previously never knew they had non-communicable diseases such as diabetes (10.4%), high cholesterol (29.8%), high blood pressure (13.8%), mental problems such as depression (1.6%) and anxiety (1.4%) other than obesity problems and so on. Prior to undergoing the PeKa B40 health screening, they had never undergone such health screening, let alone seek follow-up treatment.